| HGNC Family | Endogenous ligands |
| Name | prokineticin 2 |
| Description | This gene encodes a protein expressed in the suprachiasmatic nucleus (SCN) circadian clock that may function as the output component of the circadian clock. The secreted form of the encoded protein may also serve as a chemoattractant for neuronal precursor cells in the olfactory bulb. Proteins from other vertebrates which are similar to this gene product were isolated based on homology to snake venom and secretions from frog skin, and have been shown to have diverse functions. Mutations in this gene are associated with Kallmann syndrome 4. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPROK2 functions as a key circadian output signal in mammals. In the suprachiasmatic nucleus the peptide’s rhythmic, light‐entrained expression helps to coordinate behavioral and physiological rhythms, thereby establishing the proper timing of locomotor activity and additional circadian processes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in circadian regulation, PROK2 is critical for proper neuroendocrine reproductive development. It governs olfactory bulb morphogenesis and facilitates the migration of gonadotropin‐releasing hormone (GnRH) neurons—a process whose disruption leads to conditions such as Kallmann syndrome and idiopathic hypogonadotropic hypogonadism. Expression and mutation studies, including analyses in both human patients and mouse models, demonstrate that heterozygous and biallelic defects in PROK2 (or its receptor PROKR2) result in variable reproductive phenotypes accompanied by anosmia. Moreover, its expression in reproductive tissues such as the endometrium and fetal ovary further underscores its involvement in gonadal development and differentiation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "2", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPROK2 also exhibits potent angiogenic and tumor‐promoting activities in diverse tissues. Studies have demonstrated that PROK2 acts as an endothelial mitogen, promoting survival, proliferation, and migration of vascular and myeloid cells. Such functions contribute to neovascularization and are implicated in the progression of several malignancies—including prostate, colorectal and cervical cancers—as well as in chronic inflammatory skin disorders like psoriasis. In tumor models, PROK2 secretion enhances the recruitment of myeloid cells and supports a microenvironment conducive to tumor growth and metastasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond these roles, PROK2 modulates inflammatory responses and confers neuroprotective effects under pathological conditions. In models of neural injury—such as traumatic brain injury and subarachnoid hemorrhage—increased PROK2 signaling induces a phenotypic shift in astrocytes toward the protective “A2” state, thereby reducing proinflammatory cytokine production and lipid peroxidation that otherwise lead to neuronal ferroptosis. Altered PROK2 dynamics have also been implicated in neurodegenerative diseases like Alzheimer’s and Parkinson’s, as well as in persistent olfactory dysfunction following viral infections."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, PROK2 is emerging as an important regulator of energy balance. By acting primarily through its receptor in the amygdala, PROK2 exerts anorexigenic effects that help suppress food intake—a function modulated by accessory proteins such as MRAP2—thereby linking PROK2 signaling to the control of systemic energy homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPROK2 is also involved in peripheral inflammatory regulation and tissue remodeling. In the gastrointestinal tract and airways, the peptide acts in a cytokine‐like manner to modulate ion channel activity and inflammatory responses—evidenced by its up‐regulation in settings such as cystic fibrosis. In the uteroplacental unit, PROK2 is part of the inflammatory cascade that triggers smooth muscle contractility during labor, suggesting its potential as a therapeutic target in preterm birth."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "34", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, recent evidence indicates that PROK2 influences cardiovascular tissue remodeling via epicardium‐derived progenitor cells. By steering these progenitors away from adipogenic fates in favor of a pro‐vasculogenic lineage, PROK2 contributes to neovascularization and the maintenance of cardiac vascular integrity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "37"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Michelle Y Cheng, Clayton M Bullock, Chuanyu Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/417405a"}], "href": "https://doi.org/10.1038/417405a"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12024206"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12024206"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "S Battersby, H O D Critchley, K Morgan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2003-032012"}], "href": "https://doi.org/10.1210/jc.2003-032012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15126578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15126578"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Catherine Dodé, Luis Teixeira, Jacqueline Levilliers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.0020175"}], "href": "https://doi.org/10.1371/journal.pgen.0020175"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17054399"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17054399"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Nelly Pitteloud, Chengkang Zhang, Duarte Pignatelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0707173104"}], "href": "https://doi.org/10.1073/pnas.0707173104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17959774"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17959774"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Chrystel Leroy, Corinne Fouveaut, Sandrine Leclercq, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ejhg.2008.15"}], "href": "https://doi.org/10.1038/ejhg.2008.15"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18285834"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18285834"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Lindsay W Cole, Yisrael Sidis, ChengKang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2007-2654"}], "href": "https://doi.org/10.1210/jc.2007-2654"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18559922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18559922"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Julie Sarfati, Anne Guiochon-Mantel, Philippe Rondard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2009-0843"}], "href": "https://doi.org/10.1210/jc.2009-0843"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20022991"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20022991"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Julie Sarfati, Catherine Dodé, Jacques Young "}, {"type": "b", "children": [{"type": "t", "text": "Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Horm Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000312698"}], "href": "https://doi.org/10.1159/000312698"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20389090"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20389090"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Antoine Moya-Plana, Carine Villanueva, Ollivier Laccourreye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Endocrinol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1530/EJE-12-0578"}], "href": "https://doi.org/10.1530/EJE-12-0578"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23082007"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23082007"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yalcin Basaran, Erol Bolu, Hilmi Umut Unal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Multiplex ligation dependent probe amplification analysis of KAL1, GNRH1, GNRHR, PROK2 and PROKR2 in male patients with idiopathic hypogonadotropic hypogonadism]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endokrynol Pol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5603/ep.2013.0007"}], "href": "https://doi.org/10.5603/ep.2013.0007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24002956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24002956"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Juan Pablo Méndez, Juan Carlos Zenteno, Agustín Coronel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Triallelic digenic mutation in the prokineticin 2 and GNRH receptor genes in two brothers with normosmic congenital hypogonadotropic hypogonadism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocr Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/07435800.2014.982327"}], "href": "https://doi.org/10.3109/07435800.2014.982327"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25531638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25531638"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Sharon L Eddie, Andrew J Childs, Hazel L Kinnell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prokineticin Ligands and Receptors Are Expressed in the Human Fetal Ovary and Regulate Germ Cell Expression of COX2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2015-2330"}], "href": "https://doi.org/10.1210/jc.2015-2330"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26192875"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26192875"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Wael Traboulsi, Sophie Brouillet, Frederic Sergent, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prokineticins in central and peripheral control of human reproduction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Horm Mol Biol Clin Investig (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1515/hmbci-2015-0040"}], "href": "https://doi.org/10.1515/hmbci-2015-0040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26574895"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26574895"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shasha Zhou, Pin Li "}, {"type": "b", "children": [{"type": "t", "text": "The novel function of miR-3195 for mutant PROK2 (c.223-4C>A) degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbin.11496"}], "href": "https://doi.org/10.1002/cbin.11496"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33140874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33140874"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Jennifer LeCouter, Rui Lin, Max Tejada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0337667100"}], "href": "https://doi.org/10.1073/pnas.0337667100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12604792"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12604792"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jennifer LeCouter, Constance Zlot, Max Tejada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0407697101"}], "href": "https://doi.org/10.1073/pnas.0407697101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15548611"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15548611"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Daniela Pasquali, Valentina Rossi, Stefania Staibano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2006-0614"}], "href": "https://doi.org/10.1210/en.2006-0614"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16763065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16763065"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Cuiling Zhong, Xueping Qu, Martha Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Characterization and regulation of bv8 in human blood cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-08-1954"}], "href": "https://doi.org/10.1158/1078-0432.CCR-08-1954"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19336519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19336519"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Hidetaka Kurebayashi, Takanori Goi, Michiaki Shimada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.4385"}], "href": "https://doi.org/10.18632/oncotarget.4385"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26317645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26317645"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Xiaoqin He, Chuanbin Shen, Qiumin Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prokineticin 2 Plays a Pivotal Role in Psoriasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2016.10.022"}], "href": "https://doi.org/10.1016/j.ebiom.2016.10.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27887936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27887936"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Soichiro Sasaki, Tomohisa Baba, Hayato Muranaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of Prokineticin 2-expressing Neutrophil Infiltration in 5-Fluorouracil-induced Aggravation of Breast Cancer Metastasis to Lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-17-0845"}], "href": "https://doi.org/10.1158/1535-7163.MCT-17-0845"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29643149"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29643149"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Min-Hua Wu, Pei-Ru Wu, Yi-Hsien Hsieh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing PROK2 Inhibits Invasion of Human Cervical Cancer Cells by Targeting MMP15 Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms21176391"}], "href": "https://doi.org/10.3390/ijms21176391"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32887509"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32887509"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Roberta Lattanzi, Cinzia Severini, Rossella Miele "}, {"type": "b", "children": [{"type": "t", "text": "Prokineticin 2 in cancer-related inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2022.215838"}], "href": "https://doi.org/10.1016/j.canlet.2022.215838"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35921971"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35921971"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xiaomeng Li, Enqiang Chang, Jiang Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bv8 mediates myeloid cell migration and enhances malignancy of colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2023.1158045"}], "href": "https://doi.org/10.3389/fimmu.2023.1158045"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37090721"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37090721"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Matthew Neal, Jie Luo, Dilshan S Harischandra, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glia (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/glia.23467"}], "href": "https://doi.org/10.1002/glia.23467"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30277602"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30277602"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Roberta Lattanzi, Daniela Maftei, Carla Petrella, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cells (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/cells8111430"}], "href": "https://doi.org/10.3390/cells8111430"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31766244"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31766244"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Mian Ma, Haiying Li, Jiang Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Roles of Prokineticin 2 in Subarachnoid Hemorrhage-Induced Early Brain Injury via Regulation of Phenotype Polarization in Astrocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Neurobiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12035-020-01990-7"}], "href": "https://doi.org/10.1007/s12035-020-01990-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32572760"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32572760"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Zhongyuan Bao, Yinlong Liu, Binglin Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-24469-y"}], "href": "https://doi.org/10.1038/s41467-021-24469-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34244497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34244497"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Kentaro Noda, Bianca Dufner, Haruyasu Ito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-021-97809-z"}], "href": "https://doi.org/10.1038/s41598-021-97809-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34526577"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34526577"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Tommaso Schirinzi, Daniela Maftei, Francesco M Passali, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.26526"}], "href": "https://doi.org/10.1002/ana.26526"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36218142"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36218142"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Qian Xiang, Zhe Wang, Guangyan Mu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PROK2, HRNR, and FIG4 as potential genetic biomarkers of high bleeding propensity in East Asian patients with acute coronary syndrome using ticagrelor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacotherapy (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/phar.2736"}], "href": "https://doi.org/10.1002/phar.2736"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36263704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36263704"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Christophe Magnan, Stéphanie Migrenne-Li "}, {"type": "b", "children": [{"type": "t", "text": "Pleiotropic effects of prokineticin 2 in the control of energy metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochimie (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biochi.2021.04.009"}], "href": "https://doi.org/10.1016/j.biochi.2021.04.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33932486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33932486"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Terry C Yin, Ayushi Mittal, Paul Buscaglia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of amygdala prokineticin receptor 2 neurons drives the anorexigenic activity of the neuropeptide PK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2022.102814"}], "href": "https://doi.org/10.1016/j.jbc.2022.102814"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36539034"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36539034"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Rob D Catalano, Tamsin R M Lannagan, Marta Gorowiec, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prokineticins: novel mediators of inflammatory and contractile pathways at parturition?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Hum Reprod (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/molehr/gaq014"}], "href": "https://doi.org/10.1093/molehr/gaq014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20172976"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20172976"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Robert P Watson, Elliot Lilley, Moh Panesar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurogastroenterol Motil (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2982.2011.01804.x"}], "href": "https://doi.org/10.1111/j.1365-2982.2011.01804.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22050240"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22050240"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Sylvain Chauvet, Wael Traboulsi, Laura Thevenon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EG-VEGF, BV8, and their receptor expression in human bronchi and their modification in cystic fibrosis: Impact of CFTR mutation (delF508)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Lung Cell Mol Physiol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajplung.00382.2014"}], "href": "https://doi.org/10.1152/ajplung.00382.2014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26047640"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26047640"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Rehana Qureshi, Michel Kindo, Mounia Boulberdaa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Prokineticin-Driven Epigenetic Switch Regulates Human Epicardial Cell Stemness and Fate."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cells (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/stem.2866"}], "href": "https://doi.org/10.1002/stem.2866"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29873146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29873146"}]}]}]}
|
| Synonyms | MIT1, HH4, BV8, KAL4, PK2 |
| Proteins | PROK2_HUMAN |
| NCBI Gene ID | 60675 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PROK2 has 4,724 functional associations with biological entities spanning 8 categories (molecular profile, organism, disease, phenotype or trait, functional term, phrase or reference, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 97 datasets.
Click the + buttons to view associations for PROK2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PROK2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PROK2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PROK2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PROK2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PROK2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PROK2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PROK2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PROK2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with PROK2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PROK2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PROK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PROK2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with PROK2 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with PROK2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of PROK2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing PROK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing PROK2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with PROK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PROK2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PROK2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PROK2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PROK2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PROK2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PROK2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving PROK2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving PROK2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with PROK2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with PROK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PROK2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PROK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with PROK2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PROK2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PROK2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PROK2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PROK2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PROK2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with PROK2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PROK2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PROK2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PROK2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PROK2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PROK2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PROK2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PROK2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PROK2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PROK2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving PROK2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving PROK2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PROK2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PROK2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by PROK2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by PROK2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PROK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PROK2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PROK2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PROK2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of PROK2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PROK2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PROK2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PROK2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with PROK2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with PROK2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PROK2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PROK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PROK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PROK2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate PROK2 protein from the curated KEA Substrates of Kinases dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PROK2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PROK2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PROK2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by PROK2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting PROK2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of PROK2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by PROK2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PROK2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with PROK2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PROK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PROK2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving PROK2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving PROK2 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving PROK2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving PROK2 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of PROK2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PROK2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of PROK2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PROK2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PROK2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of PROK2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PROK2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PROK2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PROK2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of PROK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PROK2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PROK2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with PROK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PROK2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving PROK2 protein from the WikiPathways Pathways 2024 dataset. | |